Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 425 of 2051 entries
View as:

Efficacy of Peginterferon Alfa-2b in Previously Untreated Subjects With Chronic Hepatitis B and D Co-infection (Study P04603)

Phase: N/A Priority: Normal
NCT ID: NCT00686790 Org: User:
Start: 12/31/05 End: 05/31/09 Due: 05/31/10

Safety and Immunogenicity Study of V710 Lyophilized Formulation (V710-004)

Phase: N/A Priority: Normal
NCT ID: NCT00822757 Org: User:
Start: 08/31/07 End: 12/31/07 Due: 12/31/08

Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs. Placebo Plus Chemotherapy for Previously Untreated Locally Recurrent Inoperable or Metastatic Triple Negative Breast Cancer (MK-3475-355/KEYNOTE-355)

Phase: N/A Priority: Normal
NCT ID: NCT02819518 Org: User:
Start: 07/27/16 End: 10/30/23 Due: 10/30/24

Letermovir Treatment in Pediatric Participants Following Allogeneic Haematopoietic Stem Cell Transplantation (HSCT) (MK-8228-030)

Phase: N/A Priority: Normal
NCT ID: NCT03940586 Org: User:
Start: 08/08/19 End: 08/25/23 Due: 08/25/24

Study of Hepatitis C Virus (HCV) Nonstructural Protein 5a (NS5A) Inhibitor IDX719 in Healthy and HCV-Infected Participants (MK-1894-001)

Phase: N/A Priority: Normal
NCT ID: NCT01508156 Org: User:
Start: 01/31/12 End: 07/31/12 Due: 07/31/13

The Effect of Hypertension Medications on Renal Blood Flow Measurements in Healthy Males (MK-0000-127)

Phase: N/A Priority: Normal
NCT ID: NCT00856960 Org: User:
Start: 01/31/10 End: 04/30/10 Due: 04/30/11

A Study of Absorption, Metabolism, Excretion and Mass Balance After a Single Dose Administration of MK-0941 (MK-0941-016)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00912002 Org: User:
Start: 10/31/08 End: 01/31/09 Due: 01/31/10

A Study of the Efficacy and Tolerance of Remicade in the Treatment of Active Ankylosing Spondylitis (Study P04042)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00779012 Org: User:
Start: 10/01/04 End: 06/01/07 Due: 06/01/08

AP23573 in Female Adult Patients With Recurrent or Persistent Endometrial Cancer (8669-019)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00122343 Org: User:
Start: 08/31/05 End: 01/31/08 Due: 01/31/09

Pharmacokinetics of Ridaforolimus (MK-8669) in Chinese Participants (MK-8669-059)

Phase: N/A Priority: Normal
NCT ID: NCT01380184 Org: User:
Start: 07/05/11 End: 04/05/12 Due: 04/05/13

Revaccination With PNEUMOVAX(TM) 23 in Older Adults (V110-007)

Phase: N/A Priority: Normal
NCT ID: NCT00560950 Org: User:
Start: 07/31/07 End: 05/31/08 Due: 05/31/09

A Study to Evaluate Long-term Impact of VARIVAX Among Children and Adolescents (V210-036)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT01077804 Org: User:
Start: 06/01/95 End: 11/01/10 Due: 11/01/11

A Four Week, Open-Label Study of Azithromycin Ophthalmic Solution, 1% (P08641)

Phase: N/A Priority: Normal
NCT ID: NCT01220258 Org: User:
Start: 11/30/10 End: 08/31/11 Due: 08/31/12

Treatment of Patients With Major Depressive Disorder With MK0869 (0869-059)

Phase: N/A Priority: Normal
NCT ID: NCT00035009 Org: User:
Start: 09/20/01 End: 03/24/04 Due: 03/24/05

Grazoprevir (MK-5172) Administered With Peginterferon and Ribavirin in Treatment-Naïve Participants With Chronic Hepatitis C (MK-5172-003)

Phase: N/A Priority: Normal
NCT ID: NCT01353911 Org: User:
Start: 06/27/11 End: 03/10/15 Due: 03/10/16

Effect of Golimumab in Participants With Active Axial Spondyloarthritis (P07642, MK-8259-006)

Phase: N/A Priority: Normal
NCT ID: NCT01453725 Org: User:
Start: 02/13/12 End: 01/15/15 Due: 01/15/16

A Study of the Combination Regimen Grazoprevir (MK-5172) and Elbasvir (MK-8742) ± Ribavirin in Participants With Chronic Hepatitis C (MK-5172-035)

Phase: N/A Priority: Normal
NCT ID: NCT01717326 Org: User:
Start: 02/07/13 End: 05/06/15 Due: 05/06/16

Study of Pembrolizumab (MK-3475) Monotherapy in Locally Advanced/Metastatic Renal Cell Carcinoma (MK-3475-427/KEYNOTE-427)

Phase: N/A Priority: Normal
NCT ID: NCT02853344 Org: User:
Start: 09/30/16 End: 04/01/22 Due: 04/01/23

A Study of the Immunogenicity, Tolerability, and Safety of a New Formulation of RotaTeq™ in Infants (V260-035)

Phase: N/A Priority: Normal
NCT ID: NCT01600092 Org: User:
Start: 04/29/13 End: 03/25/14 Due: 03/25/15

Study of Pembrolizumab (MK-3475) or Placebo With Chemoradiation in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-412/KEYNOTE-412)

Phase: N/A Priority: Normal
NCT ID: NCT03040999 Org: User:
Start: 04/05/17 End: 08/21/24 Due: 08/21/25

Sitagliptin Metformin Add-on Study in Patients With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT00337610 Org: User:
Start: 06/30/06 End: 08/31/07 Due: 08/31/08

Efficacy and Safety of MK-1942 When Added to Stable Antidepressant Therapy in Participants With Treatment-Resistant Depression (TRD) (MK-1942-006)

Phase: N/A Priority: Normal
NCT ID: NCT04663321 Org: User:
Start: 05/20/21 End: 09/08/23 Due: 09/08/24

Induced Sputum Study (0000-065)

Phase: N/A Priority: Normal
NCT ID: NCT00623714 Org: User:
Start: 01/31/08 End: 03/31/09 Due: 03/31/10

A Study of Pembrolizumab (MK-3475) in Combination With Belzutifan (MK-6482) and Lenvatinib (MK-7902), or Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib, Versus Pembrolizumab and Lenvatinib, for Treatment of Advanced Clear Cell Renal Cell Carcinoma (MK-6482-012)

Phase: N/A Priority: Normal
NCT ID: NCT04736706 Org: User:
Start: 04/14/21 End: 10/29/26 Due: 10/29/27

Evaluate the Safety and Efficacy of Caspofungin Acetate as Empirical Therapy in Chinese Adults With Persistent Fever and Neutropenia (0991-055)

Phase: N/A Priority: Normal
NCT ID: NCT00548080 Org: User:
Start: 03/31/06 End: 11/30/06 Due: 11/30/07